© 2003 BMJ Publishing Group Ltd & Association of Clinical Pathologists
ORIGINAL ARTICLE
Serum laminin and collagen IV in inflammatory bowel disease
1 Department of Gastroenterology University Hospital Heraklion, 71110 Heraklion, Crete, Greece
2 Laboratory of Clinical Microbiology, University of Thessaly, 41222 Larissa, Greece
Correspondence to:
Correspondence to:
Dr I E Koutroubakis
Department of Gastroenterology, University Hospital Heraklion, PO BOX 1352, 71110 Heraklion, Crete, Greece; ktjohn{at}her.forthnet.gr
Background/Aims: Laminin and collagen IV have been proposed as extracellular matrix serum markers. Because fibrosis is a major complication of inflammatory bowel disease, serum concentrations of laminin and collagen IV were measured in patients with ulcerative colitis (UC) and Crohns disease (CD) and compared with inflammatory and healthy controls.
Methods: Laminin and collagen IV serum concentrations were measured in 170 patients with inflammatory bowel disease (86 UC and 84 CD), in 23 patients with other causes of intestinal inflammation, and in 80 matched healthy controls using commercially available enzyme linked immunosorbent assays. Laminin and collagen IV concentrations were correlated with disease activity, type, localisation, and treatment.
Results: Mean (SD) serum laminin concentrations were 281.0 (110.1) ng/ml in patients with UC, 275.6 (106.7) ng/ml in patients with CD, 192.0 (17.8) ng/ml in healthy controls, and 198.5 (32.5) ng/ml in inflammatory controls. Mean (SD) serum collagen IV concentrations were 72.8 (22.9) ng/ml in patients with UC, 71.0 (18.2) in patients with CD, 79.8 (12.2) ng/ml in healthy controls, and 88.9 (24.6) ng/ml in inflammatory controls. There was a significant difference among the four groups (p < 0.0001) for both markers. There was a strong correlation between serum laminin, but not collagen IV, and disease activity in both diseases. No significant association was found between these markers and disease localisation or disease type.
Conclusions: Serum concentrations of laminin are increased, whereas serum concentrations of collagen IV are decreased, in patients with inflammatory bowel disease. They may be useful surrogate markers for sustained inflammation and tissue remodelling.
Keywords: collagen; Crohns disease; fibrosis; laminin; ulcerative colitis
Abbreviations: CD, Crohns disease; CDAI, Crohns disease activity index; CRP, C reactive protein; HC, healthy control; IBD, inflammatory bowel disease; SCCAI, simple clinical colitis activity index; UC, ulcerative colitis
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Adair-Kirk, T. L., Atkinson, J. J., Kelley, D. G., Arch, R. H., Miner, J. H., Senior, R. M.
(2005). A Chemotactic Peptide from Laminin {alpha}5 Functions as a Regulator of Inflammatory Immune Responses via TNF{alpha}-mediated Signaling. J. Immunol.
174: 1621-1629
[Abstract] [Full Text] -
Li, A C Y, Thompson, R P H
(2003). Basement membrane components. J. Clin. Pathol.
56: 885-887
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
